您的位置:山东大学 -> 科技期刊社 -> 《山东大学学报(医学版)》

山东大学学报 (医学版) ›› 2018, Vol. 56 ›› Issue (7): 21-27.doi: 10.6040/j.issn.1671-7554.0.2017.493

• • 上一篇    

DRSAb对缺血再灌注损伤大鼠肾脏的保护作用

孙晶晶,张江伟,匡培丹,张颖,薛武军,郑瑾   

  1. 西安交通大学第一附属医院肾移植科, 陕西 西安 710061
  • 发布日期:2022-09-27
  • 通讯作者: 郑瑾. E-mail:jzheng@xjtu.edu.cn
  • 基金资助:
    国家自然科学基金面上项目(81670682);陕西省自然科学基础研究计划(2015JM8392)

Protective effects of DRSAb on ischemia reperfusion induced renal injury in rats

SUN Jingjing, ZHANG Jiangwei, KUANG Peidan, ZHANG Ying, XUE Wujun, ZHENG Jin   

  1. Department of Kidney Transplant, First Affiliated Hospital of Xian Jiaotong University, Xian 710061, Shaanxi, China
  • Published:2022-09-27

摘要: 目的 研究钠钾ATP酶DR区特异性抗体(DRSAb)对肾脏缺血再灌注损伤的保护作用及其机制。 方法 合成DR区多肽,免疫SD雄性大鼠制备特异性抗血清。采用Western blotting和流式细胞技术测定DRSAb的生物学活性、细胞信号传导机制;采用MTT法测定肾小管上皮细胞HK-2活性;采用缺血再灌注损伤模型检测DRSAb对缺血再灌注损伤大鼠肾脏的保护作用。 结果 90.02%的HK2细胞可以和所制备的DRSAb结合;DRSAb免疫血清可增强HK-2细胞对缺氧的耐受能力,与对照血清比较差异有统计学意义(OD: 0.50±0.03 vs 0.10±0.02,P<0.001);DRSAb可以激活PI3K/AKT激酶和PKCε激酶(P<0.001),LY294002和PEAVSLKPT可以抑制这种激活作用(P<0.001);动物实验结果显示,DRSAb组大鼠术后3~6 d血清肌酐、尿素氮水平显著低于Control组(P<0.001)。肾组织切片显示,Control组大鼠肾脏可见明显的血管充血、上皮细胞水肿和小管坏死;DRSAb组的大鼠肾脏可见轻微血管充血、上皮细胞轻度水肿,但无小管坏死。 结论 DRSAb对缺血再灌注损伤大鼠肾脏具有一定的保护作用,这种保护作用与PI3K/AKT、PKCε信号通路活化密切相关。

关键词: 缺血再灌注损伤, 钠钾ATP酶, DR区特异性抗体, PI3K/AKT, PKCε

Abstract: Objective To explore the protective effects of Na+/K+-ATPase DR region specific antibody(DRSAb)on ischemia/reperfusion induced renal injury and its mechanism. Methods Spragur-Dawley(SD)male rats were immunized with synthesised DR region peptides to prepare DRSAb. The biological activity of DRSAb was detected with Western blotting, and the mechanism of cell signal transduction was determined with flow cytometry. The activity of HK-2 cells was assessed with MTT. The protective effect of DRSAb on ischemia-reperfusion injury in rat kidney was evaluated with animal models of ischemia-reperfusion injury. Results The results showed that 90.02% of HK-2 cells could bind with DRSAb. The DRSAb immune sera could significantly enchance the tolerance of HK-2 cells to hypoxia, compared with control seara(OD: 0.50±0.03 vs 0.10±0.02, P<0.001). DRSAb could activate PI3K/AKT and PKCε kinase(P<0.001), which could be inhibited by LY294002 and PEAVSLKPT(P<0.001). Animal experiments indicated that DRSAb group demonstrated a significant improvement in renal function with a lower serum creatinine(sCr)and blood urea nitrogen(BUN)levels 3-6 days postoperative compared with the Control group(P<0.001). Histological evaluation showed that the Control group had visible vascular congestion, epithelial cell swelling and extensive tubular necrosis. 山 东 大 学 学 报 (医 学 版)56卷7期 -孙晶晶,等. DRSAb对缺血再灌注损伤大鼠肾脏的保护作用 \=-However, DRSAb group only had slight vascular congestion, mild epithelial cell edema, and no tubular necrosis. Conclusion DRSAb has protective effects against renal ischemia/reperfusion injury in rats, which is associated with the activiation of PI3K/AK and PKCε signalling pathways.

Key words: Ischemia/reperfusion, Na+/K+-ATPase, DR region specific antibody, PI3K/AKT, PKCε

中图分类号: 

  • R392.7
[1] Malek M, Nematbakhsh M. Renal ischemia/reperfusion injury; from pathophysiology to treatment [J]. J Renal Inj Prev, 2015, 4(2): 20-27.
[2] Yue TL, Wang C, Gu JL, et al. Inhibition of extracellular signal-regulated kinase enhances Ischemia/Reoxygenation-induced apoptosis in cultured cardiac myocytes and exaggerates reperfusion injury in isolated perfused heart[J]. Circ Res, 2000, 86(6): 692-699.
[3] Huang P, Sun Y, Yang J, et al. The ERK1/2 signaling pathway is involved in sulfur dioxide preconditioning-induced protection against cardiac dysfunction in isolated perfused rat heart subjected to myocardial ischemia/reperfusion[J]. Int J Mol Sci, 2013, 14(11): 22190-22201.
[4] Hausenloy DJ, Yellon DM. Survival kinases in ischemic preconditioning and postconditioning[J]. Cardiovasc Res, 2006,70(2): 240-253.
[5] Yao H, Han X, Han X. The cardioprotection of the insulin-mediated PI3K/Akt/mTOR signaling pathway[J]. Am J Cardiovasc Drugs, 2014, 14(6): 433-442.
[6] 易善红. 人促红细胞生成素对肾脏缺血再灌注的保护作用[J]. 免疫学杂志, 2007, 23(1): 49-51. YI Shanhong. Protective activity of human erythropoietin against renal ischemia-reperfusion injury[J]. Immunological Journal, 2007, 23(1): 49-51.
[7] Zheng J, Koh X, Hua F, et al. Cardioprotection induced by Na+/K+ ATPase activation involves extracellular Signal regulated kinase1/2 and phosphoinositide 3-kinase /AKT pathway[J]. Cardiovasc Res, 2011, 89(1): 51-59.
[8] Gong HL, Sun JJ, Xue WJ, et al. Protective effect of truncated Na+/K+-ATPase b on ischemia/reperfusion-induced renal injury in rats [J]. Exp Biol Med(Maywood), 2014,239(6):677-685.
[9] Aizman O, Aperia A. Na(+)/K(+)-ATPase as a signal transducer[J]. Ann N Y Acad Sci, 2003, 986(1): 489-496.
[10] Xu KY, Takimoto E, Fedarko NS. Activation of(Na+/+ K+)-ATPase induces positive inotropy in intact mouse heart in vivo[J]. Biochem Biophys Res Commun, 2006, 349(2): 582-587.
[11] Guerreroorriach JL, Belmonte JJE, Fernandez AR, et al. Cardioprotection with halogenated gases: how does it occur? [J]. Drug Des Devel Ther, 2017, 16(11): 837-849.
[12] Lee SG, Su ZZ, Emdad L, et al. Astrocyte elevated gene-1 activates cell survival pathways through PI3K-Akt signaling [J]. Oncogene, 2008, 27(8): 1114-1121.
[13] Ma ZG, Xia HQ,Cui SL, et al. Attenuation of renal ischemic reperfusion injury by salvianolic acid B via suppressing oxidative stress and inflammation through PI3K/Akt signaling pathway [J]. Braz J Med Biol Res, 2017, 50(6): e5954. doi: 10.1590/1414-431X20175954.
[14] Chen XD, Su MY, Chen TT, et al. Oxidative stress affects retinal pigment epithelial cell survival through epidermal growth factor receptor/AKT signaling pathway[J]. Int J Ophthalmol, 2017, 10(4): 507-514.
[15] Guo XQ, Cao YL, Hao F, et al. Tangeretin alters neuronal apoptosis and ameliorates the severity of seizures in experimental epilepsy-induced rats by modulating apoptotic protein expressions, regulating matrix metalloproteinases, and activating the PI3K/Akt cell survival pathway [J]. Adv Med Sci, 2017, 62(2): 246-253.
[16] Yao H, Han X, Han X. The cardioprotection of the insulin-mediated PI3K/Akt/mTOR signaling pathway [J]. Am J Cardiovasc Drugs, 2014, 14(6): 433-442.
[17] Madonna R, Bolli R, Rokosh G, et al. Targeting phosphatidylinositol 3-kinase-Akt through hepatocyte growth factor for cardioprotection [J]. J Cardiovasc Med, 2013, 14(4): 249-253.
[18] Yu ZH, Cai M, Xiang J, et al. PI3K/Akt pathway contributes to neuroprotective effect of Tongxinluo against focal cerebral ischemia and reperfusion injury in rats [J]. J Ethnopharmacol, 2016, 2(181): 8-19.
[19] Peng Y, Pu J, Tang C, et al. Curcumin inhibits heat-induced apoptosis by suppressing NADPH oxidase 2 and activating theAkt/mTOR signaling pathway in bronchial epithelial cells[J]. Cell Physiol Biochem, 2017, 41(5): 2091-2103.
[20] Antal CE, Newton AC. Tuning the signaling output of protein kinase C.[J]. Biochem Soc Trans, 2014, 42(6): 1477-1483.
[21] Kang JH, Toita R, Kim CW, et al. Protein kinase C(PKC)isozyme-specific substrates and their design[J]. Biotechnol Adv, 2012, 30(6): 1662-1672.
[22] Newton AC, Antal CE, Steinberg SF. Protein kinase C mechanisms that contribute to cardiac remodeling[J]. Clin Sci, 2016, 130(17): 1499-1510.
[23] Ferreira JC, Brum PC, Mochly-Rosen D.βIIPKC and εPKC isozymes as potential pharmacological targets in cardiac hypertrophy and heart failure [J]. J Mol Cell Cardiol, 2011, 51(4): 479-484.
[24] Newton AC, Brognard J. Reversing the paradigm:protein kinase C as a tumor suppressor[J]. Trends Pharmacol Sci, 2017, 38(5): 438-447.
[25] Simkhovich BZ, Przyklenk K, Kloner RA. Role of protein kinase C in ischemic “conditioning”: from first evidence to current perspectives[J]. J Cardiovasc Pharmacol Ther, 2013, 18(6): 525-532.
[1] 张倩,秦明明,何学佳,蔡秋景,张亚民,李庆苏,朱薇薇. 骨化三醇对哮喘中TGF-β1所诱导上皮间充质转化的调控作用[J]. 山东大学学报 (医学版), 2021, 59(7): 10-18.
[2] 龙婷婷,谢明,周璐,朱俊德. Noggin蛋白对小鼠脑缺血再灌注损伤后学习和记忆能力与齿状回结构的影响[J]. 山东大学学报 (医学版), 2020, 1(7): 15-23.
[3] 梁丽宁,钟霞,季宪飞,胡浩然,朱芳芳,陈吉彬,陈茜茜,商德亚. 尼可地尔后适应对猪心脏骤停后心脑肾缺血再灌注损伤的保护作用[J]. 山东大学学报(医学版), 2017, 55(10): 46-51.
[4] 赵秀芹,邓春颖,李世英,张晋霞,贺永贵,余红,刘斌. 丁苯酞注射液对大鼠局灶性脑缺血再灌注损伤的神经保护作用[J]. 山东大学学报(医学版), 2016, 54(4): 25-31.
[5] 李欣,王公明,王红,王岩,张立功,张乐,刘蓓,张孟元. 诱导型一氧化氮合成酶参与大鼠心脏缺血后处理延迟相的保护作用[J]. 山东大学学报(医学版), 2016, 54(2): 16-20.
[6] 李少伟, 刘宗正, 刘春霞, 张焱如, 周欢敏. 葡萄籽原花青素对小鼠脂肪肝模型缺血再灌注造成的急性肝损伤的保护作用[J]. 山东大学学报(医学版), 2015, 53(9): 41-46.
[7] 李少伟, 刘宗正, 刘春霞, 张焱如, 周欢敏. 口服富氢水对小鼠脂肪肝缺血再灌注损伤的保护作用[J]. 山东大学学报(医学版), 2015, 53(1): 10-15.
[8] 朱裕华1,袁红花2,吴连连2,胡安康1,陈仁金1,朱孝荣1. IGF-1通过PI3K/Akt信号通路诱导神经干细胞向神经元分化[J]. 山东大学学报(医学版), 2014, 52(3): 11-15.
[9] 葛均克,赵升田. 骨髓间充质干细胞与CD133+肾脏细胞对急性肾损伤的疗效[J]. 山东大学学报(医学版), 2013, 51(9): 55-59.
[10] 刘善文1,王福1, 李彬2,耿海华3,李彩娥4,许哲5,李睿1,肖洁1,张森1,季晓平1. 大鼠骨髓间充质干细胞exosome提取及其心肌细胞H9C2靶向作用的实验探索[J]. 山东大学学报(医学版), 2013, 51(9): 1-7.
[11] 靳斌1,王伟2,刘泽阳1,李广振1,杜刚1,张宗利1,韩立涛1,黄国振1,唐振宇1. 外源hTERT基因转染对老年大鼠供肝缺血再灌注损伤的防护作用[J]. 山东大学学报(医学版), 2013, 51(8): 13-16.
[12] 刘硕硕,张斌,郭婷婷,董肖婷. PTEN基因转染对人舌鳞癌细胞系SCC-4凋亡的影响及其作用机制[J]. 山东大学学报(医学版), 2013, 51(1): 42-45.
[13] 丁明1, 宗波1, 王学平2. 芬太尼及甲泼尼龙琥珀酸钠对家兔骨骼肌缺血再灌注损伤的保护机制[J]. 山东大学学报(医学版), 2012, 50(9): 55-58.
[14] 谭海波1,于灵芝1,边雯2,张文嘉1,张刚1,张娜1,石秀芳1. 脑缺血再灌注后大鼠氧化水平和神经功能损伤及异丙酚的影响[J]. 山东大学学报(医学版), 2010, 48(1): 41-44.
[15] 孙俊萍,张娟,宋兆峰,李晓星,季晓平. Rho激酶在乳鼠心肌细胞模拟缺血再灌注损伤细胞凋亡中的作用[J]. 山东大学学报(医学版), 2008, 46(5): 498-501.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!